Comparison of dextranomer and streptokinase-streptodornase in the treatment of venous leg ulcers and other infected wounds.
The clinical efficacy of dextranomer (Debrisan) and streptokinase-streptodornase (Varidase) was compared in a controlled randomized in-patient study. There were two patient groups: Group A consisting of 28 patients with a total of 31 venous leg ulcers and Group B consisting of 56 patients with other infected wounds (posttraumatic and postoperative wounds, amputation stumps, burn wounds, arteriosclerotic ulcers, decubital ulcers, ulcers due to bone disease, rheumatic ulcers, ulcers due to erysipelas and wounds of mixed aetiology). Both agents have a good cleansing effect as well as a good effect on infection and wet necrosis. Dextranomer stimulates the formation of granulation tissue faster than streptokinase-streptodornase.
D001424:Bacterial Infections / Q000188:drug therapy*; D003911:Dextrans / Q000627:therapeutic use*; D006801:Humans; D007871:Leg Ulcer / Q000188:drug therapy*; D013299:Streptodornase and Streptokinase / Q000627:therapeutic use*; D014946:Wound Infection / Q000188:drug therapy*
D003911:Dextrans; C013471:dextranomer; D013299:Streptodornase and Streptokinase